Literature DB >> 15544530

Sunflower trypsin inhibitor-1.

Michael L J Korsinczky1, Horst Joachim Schirra, David J Craik.   

Abstract

SFTI-1 is a bicyclic 14 amino acid peptide that was originally isolated from the seeds of the sunflower Helianthus annuus. It is a potent inhibitor of trypsin, with a sub-nanomolar K(i) value and is homologous to the active site region of the well-known family of serine protease inhibitors known as the Bowman-Birk trypsin inhibitors. It has a cyclic backbone that is cross-braced by a single disulfide bridge and a network of hydrogen bonds that result in a well-defined structure. SFTI-1 is amenable to chemical synthesis, allowing for the creation of synthetic variants. Alterations to the structure such as linearising the backbone or removing the disulfide bridge do not reduce the potency of SFTI-1 significantly, and minimising the peptide to as few as nine residues results in only a small decrease in reactivity. The creation of linear variants of SFTI-1 also provides a tool for investigating putative linear precursor peptides. The mechanism of biosynthesis of SFTI-1 is not yet known but it seems likely that it is a gene-coded product that has arisen from a precursor protein that may be evolutionarily related to classic Bowman-Birk inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15544530     DOI: 10.2174/1389203043379594

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  14 in total

1.  Peptide bicycles that inhibit the Grb2 SH2 domain.

Authors:  Justin S Quartararo; Pianpian Wu; Joshua A Kritzer
Journal:  Chembiochem       Date:  2012-06-11       Impact factor: 3.164

Review 2.  Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.

Authors:  Dipankar Chaudhuri; Teshome Aboye; Julio A Camarero
Journal:  Biochem J       Date:  2019-01-11       Impact factor: 3.857

3.  An engineered cyclic peptide alleviates symptoms of inflammation in a murine model of inflammatory bowel disease.

Authors:  Claudia Cobos Caceres; Paramjit S Bansal; Severine Navarro; David Wilson; Laurianne Don; Paul Giacomin; Alex Loukas; Norelle L Daly
Journal:  J Biol Chem       Date:  2017-05-04       Impact factor: 5.157

4.  Efficient recombinant expression of SFTI-1 in bacterial cells using intein-mediated protein trans-splicing.

Authors:  Yilong Li; Teshome Aboye; Leonard Breindel; Alexander Shekhtman; Julio A Camarero
Journal:  Biopolymers       Date:  2016-11       Impact factor: 2.505

Review 5.  Biological activities of natural and engineered cyclotides, a novel molecular scaffold for peptide-based therapeutics.

Authors:  Angie E Garcia; Julio A Camarero
Journal:  Curr Mol Pharmacol       Date:  2010-11       Impact factor: 3.339

6.  A Facile N-Mercaptoethoxyglycinamide (MEGA) Linker Approach to Peptide Thioesterification and Cyclization.

Authors:  Patrick M M Shelton; Caroline E Weller; Champak Chatterjee
Journal:  J Am Chem Soc       Date:  2017-03-09       Impact factor: 15.419

7.  Sunflower trypsin inhibitor 1 derivatives as molecular scaffolds for the development of novel peptidic radiopharmaceuticals.

Authors:  Regine García Boy; Walter Mier; Eva Maria Nothelfer; Annette Altmann; Michael Eisenhut; Harald Kolmar; Michael Tomaszowski; Susanne Krämer; Uwe Haberkorn
Journal:  Mol Imaging Biol       Date:  2009-11-24       Impact factor: 3.488

8.  Selection of peptomeric inhibitors of bovine alpha-chymotrypsin and cathepsin G based on trypsin inhibitor SFTI-1 using a combinatorial chemistry approach.

Authors:  Anna Łegowska; Dawid Debowski; Adam Lesner; Magdalena Wysocka; Krzysztof Rolka
Journal:  Mol Divers       Date:  2009-04-09       Impact factor: 2.943

9.  In vivo biosynthesis of an Ala-scan library based on the cyclic peptide SFTI-1.

Authors:  Jeffrey Austin; Richard H Kimura; Youn-Hi Woo; Julio A Camarero
Journal:  Amino Acids       Date:  2009-08-14       Impact factor: 3.520

10.  Diverse backbone-cyclized peptides via codon reprogramming.

Authors:  Takashi Kawakami; Atsushi Ohta; Masaki Ohuchi; Hiroshi Ashigai; Hiroshi Murakami; Hiroaki Suga
Journal:  Nat Chem Biol       Date:  2009-10-25       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.